- Home
- SIMO vs NVAX Comparison
SIMO vs NVAX Comparison
Compare SIMO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- NVAX
- Stock Information
- Founded
- SIMO 1995
- NVAX 1987
- Country
- SIMO Hong Kong
- NVAX United States
- Employees
- SIMO N/A
- NVAX N/A
- Industry
- SIMO Semiconductors
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIMO Technology
- NVAX Health Care
- Exchange
- SIMO Nasdaq
- NVAX Nasdaq
- Market Cap
- SIMO 2.4B
- NVAX 1.3B
- IPO Year
- SIMO 2005
- NVAX 1995
- Fundamental
- Price
- SIMO $72.14
- NVAX $6.93
- Analyst Decision
- SIMO Strong Buy
- NVAX Buy
- Analyst Count
- SIMO 8
- NVAX 5
- Target Price
- SIMO $80.63
- NVAX $16.60
- AVG Volume (30 Days)
- SIMO 309.8K
- NVAX 4.9M
- Earning Date
- SIMO 07-30-2025
- NVAX 08-07-2025
- Dividend Yield
- SIMO 2.72%
- NVAX N/A
- EPS Growth
- SIMO 59.19
- NVAX N/A
- EPS
- SIMO 2.80
- NVAX 2.97
- Revenue
- SIMO $780,733,000.00
- NVAX $1,254,962,000.00
- Revenue This Year
- SIMO $2.23
- NVAX $56.85
- Revenue Next Year
- SIMO $13.23
- NVAX N/A
- P/E Ratio
- SIMO $26.27
- NVAX $2.30
- Revenue Growth
- SIMO 10.84
- NVAX 25.92
- 52 Week Low
- SIMO $37.21
- NVAX $5.01
- 52 Week High
- SIMO $82.64
- NVAX $17.81
- Technical
- Relative Strength Index (RSI)
- SIMO 59.71
- NVAX 51.12
- Support Level
- SIMO $71.84
- NVAX $6.54
- Resistance Level
- SIMO $75.31
- NVAX $7.20
- Average True Range (ATR)
- SIMO 2.02
- NVAX 0.28
- MACD
- SIMO -0.50
- NVAX 0.06
- Stochastic Oscillator
- SIMO 47.42
- NVAX 66.36
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.